cyanopindolol has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anlar, B; Arnason, BG; Karaszewski, JW; Kim, WC; Reder, AT | 1 |
| Arnason, BG; Brown, M; Karaszewski, JW; Maselli, R; Reder, AT | 1 |
2 other study(ies) available for cyanopindolol and Multiple Sclerosis
| Article | Year |
|---|---|
Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell.
Topics: Adult; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Autoimmune Diseases; CD28 Antigens; CD8 Antigens; Cells, Cultured; Humans; Interleukin-2; Lymphocyte Activation; Middle Aged; Models, Biological; Multiple Sclerosis; Neurons, Afferent; Pindolol; Receptors, Adrenergic, beta; Recombinant Proteins; T-Lymphocyte Subsets; Up-Regulation | 1991 |
Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis.
Topics: Adult; Binding, Competitive; Cyclic AMP; Electric Stimulation; Female; Humans; Male; Membrane Potentials; Middle Aged; Multiple Sclerosis; Pindolol; Receptors, Adrenergic, beta; Skin; Sympathetic Nervous System; T-Lymphocytes | 1990 |